Ingevity Corp Files Proxy Statement

TL;DR

Ingevity filed its proxy statement on 2/25/25. Standard stuff, no fee.

AI Summary

Ingevity Corporation filed a DEFA14A on February 25, 2025, related to its proxy statement. The filing is for the company itself, Ingevity Corp, and concerns soliciting material under Rule 14a-12. No fee was required for this filing.

Why It Matters

This filing is a standard proxy statement, indicating the company is preparing for shareholder meetings or votes, which are crucial for corporate governance and decision-making.

Risk Assessment

Risk Level: low — This is a routine proxy statement filing with no immediate financial or strategic implications disclosed.

Key Players & Entities

• Ingevity Corp (company) — Registrant
• 0001140361-25-005894 (filing_id) — Accession Number
• 20250225 (date) — Filing Date
• 4920 O'HEAR AVENUE (address) — Business and Mailing Address
• NORTH CHARLESTON, SC (location) — Business and Mailing Address

FAQ

From the Filing

0001140361-25-005894.txt : 20250225 0001140361-25-005894.hdr.sgml : 20250225 20250225172745 ACCESSION NUMBER: 0001140361-25-005894 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250225 DATE AS OF CHANGE: 20250225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 25665065 BUSINESS ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 DEFA14A 1 ef20044364_defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A   Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.      )   Filed by the Registrant   ☒   Filed by a party other than the Registrant   ☐   Check the appropriate box:   ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☐ Definitive Additional Materials ☒ Soliciting Material Pursuant to §240.14a-12   INGEVITY CORPORATION (Name of Registrant as Specified In Its Charter)   (Name of Person(s) Filing Proxy Statement, if Other Than The Registrant)   Payment of Filing Fee (Check the appropriate box):   ☒ No fee required. ☐ Fee paid previously with preliminary materials. ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 On February 25, 2025, Ingevity Corporation (the “Company”) issued the following press release. A copy of the stockholder letter included in the press release was also sent directly to certain stockholders of the Company. Ingevity Highlights Significant Momentum on Actions Underway to Drive Improved Performance and Value Creation Delivered Record Year in Performance Materials and Strategic Repositioning in Performance Chemicals Is Already Demonstrating Results Business Portfolio Review Is Progressing with Recently Announced Strategic Alternatives Process for Industrial Specialties Product Line and Evaluation of Additional Portfolio and Cost Reduction Actions Ongoing Provides Information About Engagement with Vision One NORTH CHARLESTON, S.C., – February 25, 2025 – Ingevity Corporation (NYSE: NGVT) today issued the following letter to stockholders in response to the presentation issued by Vision One Management Partners (“Vision One”) earlier today: Dear Ingevity Stockholders, The Ingevity Board of Directors and leadership team are committed to taking aggressive actions to deliver significant, sustainable value creation for all Ingevity stockholders. Over the last year, we have undertaken a broad range of initiatives to enhance our business performance, improve our portfolio and strengthen our governance. These initiatives include: • Delivering a record year for Performance Materials. In 2024, we delivered record performance for our Performance Materials business for both sales and EBITDA, with margins surpassing 50%, driven by new pricing and operational efficiency initiatives. We expect continued momentum in this business as we see ICE vehicles continue to become more fuel efficient, as well as consumer preferences trending toward hybrids. We are also making progress in developing new markets for our carbon technologies in silicon anode batteries through our investment in Nexeon. • Transforming our Performance Chemicals segment. We have made signif